isatuximab with vrd in pts with newly diagnosed multiple myeloma non-eligible for transplant
Published 5 years ago • 111 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
4:34
isatuximab shows benefit in transplant-ineligible patients with newly diagnosed multiple myeloma
-
4:33
dara‐vrd vs. vrd in pts with newly diagnosed myeloma eligible for asct
-
12:37
isa-vrd vs vrd for transplant-ineligible patients with newly diagnosed multiple myeloma (imroz)
-
4:24
addition of isatuximab to rvd as induction therapy for newly-diagnosed, transplant-eligible mm pts
-
14:31
isatuximab len/dex/bortezomib vs isard in newly diagnosed transplant ineligible multiple myeloma
-
10:37
isatuximab, lenalidomide, bortezomib, and dex for newly-diagnosed multiple myeloma: gmmg-hd7
-
1:52
analyzing isatuximab in quadruplet combinations in transplant-ineligible multiple myeloma
-
4:24
isatuximab vrd or vcd in newly diagnosed transplant-ineligible myeloma
-
3:43
what treatment is recommended for a newly diagnosed patient?
-
17:02
dara rvd in pts w/transplant eligible newly diagnosed multiple myeloma after 24 months maintenance
-
2:23
management of newly diagnosed patients with multiple myeloma not eligible for transplantation
-
5:05
survival analysis of newly diagnosed transplant-eligible myeloma pts in the randomized forte trial
-
11:06
krd vs vrd as induction therapy in newly diagnosed high-risk multiple myeloma
-
15:30
overall survival results in transplant-ineligible newly diagnosed mm pts: phase 3 maia study
-
3:52
isatuximab short-duration fixed-volume infusion plus vrd for transplant-ineligible myeloma
-
4:36
what is isatuximab? and how does it compare with daratumumab?
-
6:09
myeloma made simple: treatment for patients not undergoing transplant (non-asct transplant eligible)
-
4:13
what can newly diagnosed myeloma patients expect in regard to treatment in 2020?
-
4:20
what were the results of the determination trial presented at asco and eha?